DOI: http://dx.doi.org/10.18203/2349-3933.ijam20182130

Assessment of serum cardiac troponin-I over serum CPK-MB in early diagnosis of acute myocardial infarction (AMI)

Santosh Kumar, Sachin Patil

Abstract


Background: The early mortality rate from AMI is 30% with about half of them occurring within 1hour of disability. Although the mortality rate after admission for AMI has declined by 30% over the past decades, approximately 1 of every 25 patients who survive the initial hospitalization die in the first year after AMI. The gold standard for diagnosis of MI has been an elevated serum level of creatinine kinase – myocardial band (CK- MB), the cardiac-specific isoenzyme of CK. However, elevated CK-MB may not detect all myocardial necrosis. In patients who die suddenly after severe or silent episodes of ischemia, autopsies frequently reveal micronecrosis that was not reflected in routine CK-MB measurements. The present study was undertaken to know that serum Cardiac Troponin-I is more sensitive marker than serum CPK-MB in early diagnosis of acute myocardial infarction (AMI).

Methods: The study was carried out in tertiary care hospital in Gulbarga. The study was undertaken with an aim to study that serum cardiac troponin-I (cTnl) is more sensitive than serum CK-MB in early diagnosis of acute myocardial infarction (AMI). The study was conducted on patients admitted with history of chest pain suggestive of AMI as diagnosed by WHO criteria to medicine ward of Basaveshwar Teaching and General Hospital, Gulbarga. The period of study was from June 2012 to June 2014. The sample size included 100 patients with history of chest pain suggestive of AMI, selected by simple random method.

Results: Our results revealed that cardiac troponin I was more sensitive (62%) than CK-MB in overall cases admitted in between 6-24 hrs from the onset of chest pain. Maximum number (41%) of AMI patients were affected on the anterior wall followed by Inferior wall of AMI. 11 percent were affected with Antero lateral wall wereas 5 to 6 percent were affected with anteroseptal and global acute and right ventricular AMI was seen among 2 percent of patients. Anterior wall AMI was the significantly affected site with AMI (ʎ2:12.5, P:0.0004). The maximum number of acute myocardial infarctions were ST elevation myocardial infarctions. 28% of cases where CKMB is normal, the cTnI detects the AMI cases indicating its sensitivity.

Conclusions: Cardiac troponin-I (cTnI) was more sensitive serum marker than CKMB in the early diagnosis of acute myocardial infarction (AMI). Anterior wall was the most significantly affected site of AMI. In the future, further improvements in analytical performance may open additional diagnostic windows.


Keywords


Acute myocardial infarction, Serum cardiac troponin-I, Serum CPK-MB

Full Text:

PDF

References


Newby LK, Goldmann BU, Ohman EM. Troponin: an important prognostic marker and risk-stratification tool in non–ST-segment elevation acute coronary syndromes. J Am Coll Cardiol. 2003;41:31S-36S.

Levine SA. Coronary thrombosis: Its variable clinical features. Medicine. 1929;8:245.

Huggins GA, Ogara PT. Clinical presentation and diagnostic evaluation In: Fuste V, Ross R and topol EJ (Eds): Atherosclerosis and CAD. Philadelphia 1996; Lippincott-Raven.

Shell W, Kjekshus JK, Sobel BE. Quantitative assessment of the extent. MI in the conscious dog by means of analysis of serial changes in estimation of infarct size. Circulation. 1975;52:743-54.

Killip T, Kumball JT. Treatment of AMI in coronary care unit: A 2 year experience with 250 patients. Am J Cardiol. 1967;20:457.

Riley CP, Russel ROJ, Rackley CE. Left ventricular gallop sound and AMI. Am Heart J 1973;86:598.

Falk E. Coronary thrombosis, pathogenesis and clinical manifestations. Am J Cardiol. 1991;68:28B.

Falk B, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657.

Paoli G, Mantovani P, Ardissino D. Pathologenesis of ACS: the activated plaque. Ital Heart J. 2005 May 6; 53:129.

Hayashi T, Kiyoshima T et al. Plaque erosion in the culprit lesion is prone to develop a smaller MI size-compared with plaque rupture. Am Heart J. 2005 Feb;149(2):986-1001.

Mario D’Costa M, Fleming E, Patterson MC. Cardiac troponin-I for the diagnosis of AMI in the emergency department. Am J Clin Pathol. 1997 Nov: 108(5):550-5.

Zurich SW, Qamer AU, Wordmann MJ, Lzak LS, McPhreson CA and Bernstein LH. Value of a single troponin-I at the time of presentation as compared to CK-MB determination in patients with suspected myocardial infarction. Clin Chim Acta. 2002;326:185-92.

Tanajura. AMI in adult patients. Arq Bros Cardiol. 1990;55(4):237-40.

McCord 1, Nowak RM, McCullough PA. Ninety minute exclusion of AMI by use of quantitative point of care testing (POCT) of myoglobin and troponin-I. Circulation. 2001;104:1483-8.

Collinson P, Stubbs P, Kessler AC. Multicentre evaluation of the diagnostic value of cTnI, CK-MB and myoglobin for assessing patients with suspected ACS in routine clinical practice. Heart. 2003;89:280.

Klieman, Gerhardt W, Nordin G, Ljungdah L. Can troponin-I replace CK-MB mass as “Gold Standard” for AMI? Scand J Clin Lab. 1999;230:83-9.